Internet Archive Scholar

Daptomycin-Related Rhabdomyolysis Complicated by Severe Hyperkalemia and Acute Kidney Injury

Yoshito Nishimura
2022 Cureus  

Preserved Fulltext

fulltext thumbnail
Web Archive Capture PDF (89.6 kB)
https://web.archive.org/web/20221002153654/https://assets.cureus.com/uploads/case_report/pdf/113477/20220930-18123-7iz08y.pdf

A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2022; you can also visit the original URL. The file type is application/pdf.

We describe a case of a 65-year-old man who presented with progressive generalized weakness. He was started on daptomycin for methicillin-resistant Staphylococcus aureus (MRSA) right fifth metatarsal osteomyelitis. Laboratory testing revealed severe hyperkalemia of 7.5 mEq/L (normal range: 3.3-5.1) and acute kidney injury (AKI) stage 1 associated with a substantial elevation in serum creatine kinase (CK). He had been on a high-intensity statin for years, and daptomycin was switched to
more » ... and statin was held as daptomycin-related rhabdomyolysis was suspected. Our case highlights the importance of seeking alternatives to daptomycin for patients on chronic statins.
doi:10.7759/cureus.29764 fatcat:ybe3sqcxz5e4zazzjjpcqlq4my
DOAJ
Citation

Yoshito Nishimura. "Daptomycin-Related Rhabdomyolysis Complicated by Severe Hyperkalemia and Acute Kidney Injury." Cureus (2022)